KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Medpace Holdings (MEDP) over the last 6 years, with Q3 2025 value amounting to $29.0 million.

  • Medpace Holdings' Shares Outstanding (Weighted Average) fell 648.69% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year decrease of 648.69%. This contributed to the annual value of $31.0 million for FY2024, which is 76.49% up from last year.
  • Medpace Holdings' Shares Outstanding (Weighted Average) amounted to $29.0 million in Q3 2025, which was down 648.69% from $29.5 million recorded in Q2 2025.
  • Medpace Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $35.9 million during Q4 2021, with a 5-year trough of $29.0 million in Q3 2025.
  • Over the past 5 years, Medpace Holdings' median Shares Outstanding (Weighted Average) value was $31.0 million (recorded in 2024), while the average stood at $31.8 million.
  • As far as peak fluctuations go, Medpace Holdings' Shares Outstanding (Weighted Average) tumbled by 1119.77% in 2023, and later soared by 105.46% in 2024.
  • Medpace Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $35.9 million in 2021, then fell by 9.69% to $32.4 million in 2022, then decreased by 5.14% to $30.7 million in 2023, then rose by 0.76% to $31.0 million in 2024, then fell by 6.22% to $29.0 million in 2025.
  • Its last three reported values are $29.0 million in Q3 2025, $29.5 million for Q2 2025, and $30.4 million during Q1 2025.